Treatment

Immunotherapy with CD19 CAR redirected T cells for relapsed paediatric ALL (CARPALL)

Enhancer of Zest Homolog 2 (EZH2) as a therapeutic target in Rhabdomyosarcomas

The molecular basis for the alternative lengthening of telomeres in telomerase negative cancers

Oncogenic LGR5-mediated Wnt signalling as a target for neuroblastoma therapy

Enhancing immunity against neuroblastoma through the exploitation of antigen-specific T cell co-stimulation receptors

Molecularly Guided Treatment in Childhood Cancer